ZPY-36666-12985
3 vaccinations
9 coded responses
34 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 074 / NJ
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Dose 1 — Moderna
-
2021-01-18
Registered in v-safe
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain, Injection site pruritus, Injection site warmth, Rash macular — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tirednessFree text: A red blotchy patch a few inches below the injection site that was warm to touch sore and a little itchyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-19
Survey response — days 1–6 daily, dose 1MedDRA: Erythema, Rash macular — Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tirednessFree text: Red blotchy area has faded and is mild nowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Health check-in — day 7, dose 1Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-01-27
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling — Feeling: FairFree text: The red area at the injection site came back and was swollen and had a lump under the skin. It was also itchy. It is starting to feel a little better today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
-
2021-02-10
Dose 2 — Moderna
-
2021-02-10
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · HeadacheAdult check-in
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-02-15
-
2021-02-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-17
-
2021-02-24
Survey response — day 14, dose 2MedDRA: Dizziness, Fatigue — Feeling: FairFree text: Dizziness, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-10
- 2021-03-19
-
2021-03-26
Survey response — day 42, dose 2MedDRA: Office visit, Oral disorder, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Tongue sore/lesion but I have a hx of oral cancer as well. · Healthcare visit (other): In person dr apptMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-12
- 2021-08-11
-
2021-11-16
Dose 3 — Moderna
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-12-02
- 2021-12-07
- 2021-12-14
-
2021-12-21
Survey response — day 35, dose 3MedDRA: Dizziness, Headache — Feeling: FairFree text: Headaches and dizzinessMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Survey response — day 42, dose 3MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID 19MedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-15
- 2022-05-17
-
2022-11-16
Survey response — 12 months, dose 3MedDRA: Leukoplakia, Pre-existing disease, Surgery — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Recurrence of leukoplakia requiring surgery due to being an (oral cancer survivor) two occurrences in one year. Prior dates were many years apart.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-17
-
2022-11-17
Callback requested for05:00PM ET
-
2022-11-17
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Moderna | |
| 2 | 2021-02-10 | Moderna | |
| 3 | 2021-11-16 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-26 | Successful 2022-01-14 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-11-16 | Successful 2022-11-17 |
Participant prefers to complete VAERS report online |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): A red blotchy patch a few inches below the injection site that was warm to touch sore and a little itchy
Systemic reaction (other): Red blotchy area has faded and is mild now
Release 2 — day 14, dose 1
Symptoms: The red area at the injection site came back and was swollen and had a lump under the skin. It was also itchy. It is starting to feel a little better today.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 4 — day 14, dose 2
Symptoms: Dizziness, fatigue
Release 6 — day 42, dose 2
Symptoms: Tongue sore/lesion but I have a hx of oral cancer as well.
Healthcare visit (other): In person dr appt
Release 10 — day 35, dose 3
Symptoms: Headaches and dizziness
Release 10 — day 42, dose 3
Symptoms: COVID 19
Release 12 — 12 months, dose 3
Symptoms: Recurrence of leukoplakia requiring surgery due to being an (oral cancer survivor) two occurrences in one year. Prior dates were many years apart.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Leukoplakia | · | · | ✓ |
| SD | Oral disorder | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Surgery | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Rash macular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release